KBC Group
EOLS icon

KBC Group’s Evolus EOLS Stock Holding History

KBC Group’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,451
Closed -$54K – 1744
2025
Q1 		$54K Hold
4,451
– – ﹤0.01% 1769
2024
Q4 		$49K Buy
+4,451
New +$62.6K ﹤0.01% 1817

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBC Group's EOLS Position: Q2 2025 in Review

KBC Group sold out of Evolus (EOLS) in Q2 2025, closing a stake of 4,451 shares — an estimated $54K sold.

KBC Group first reported a position in EOLS in Q4 2024 and held it in 2 quarters. The position peaked at $54K in Q1 2025. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • KBC Group reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • KBC Group sold 4,451 Evolus shares in Q2 2025, an estimated $54K.
  • KBC Group first reported a position in Evolus in Q4 2024 and held it in 2 quarters.
  • KBC Group's Evolus position peaked at $54K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.